Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Genitourinary 2 Tumor-Agnostic 1 Thoracic 1 Gynecologic 1

Conditions

Interventions

Gemcitabine 13 pembrolizumab 12 Capecitabine 9 Irinotecan 8 Erlotinib Hydrochloride 8 Carboplatin 8 Blood Specimen Collection 8 Nivolumab 7 Docetaxel 7 Cisplatin 7 Cetuximab 7 Paclitaxel 6 Everolimus 6 130-nm albumin-bound paclitaxel 6 vadimezan 5 Magnetic Resonance Spectroscopy 5 Fluorouracil 5 Cyclophosphamide 5 trametinib 4 Leucovorin 4 Lapatinib 4 Ipilimumab 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 temsirolimus 3 atezolizumab 3 abemaciclib 3 Trastuzumab 3 Radiotherapy 3 Radiation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × sacituzumab govitecan × Tumor-Agnostic × Clear all

NCT05097599 2025-01-08

StrataPATH

Strata Oncology

Phase 2 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡